Recap: Usana Health Sciences Q4 Earnings
Shares of Usana Health Sciences (NYSE:USNA) rose in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were up 32.62% year over year to $1.87, which beat the estimate of $1.43.
Revenue of $310,521,000 higher by 14.46% year over year, which beat the estimate of $291,540,000.
Looking Ahead
USANA Health Sciences Sees FY21 EPS $6.00-$6.45 vs $5.77 Est., Sales $1.21B-$1.27B vs $1.19B Est.
Price Action
Company's 52-week high was at $92.26
Company's 52-week low was at $43.01
Price action over last quarter: Up 19.02%
Company Profile
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe, with the majority of its revenue generated from markets outside the United States.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
